Some chemicals in cosmetics and other personal products (shampoo, soap, toothpaste, etc.) have been linked to a variety of serious health effects in women, men, and children. Currently, the U.S. Food and Drug Administration (FDA) has very limited authority and resources to regulate cosmetics, so the agency is not screening for chemicals that could be...
On September 17 the Endocrine Society helped sponsor the 3rd annual “Rally for Medical Research Hill Day” in Washington, D.C. The event proved to be an extraordinary day on Capitol Hill with nearly 300 people from more than 120 different organizations coming together, from 40 states, plus Washington D.C. to visit House and Senate offices...
As part of a comprehensive approach to enhance the visibility of endocrinology among research funding agencies, the Society participated in the June 4 meeting of the National Advisory Child Health and Human Development Council (NACHHD). The Council advises the director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) on...
Society Prompts United Healthcare Coverage of Low Threshold Suspend Devices
In response to advocacy efforts of the Endocrine Society and other organizations concerned with the care of patients with diabetes, United Healthcare has decided to provide coverage for low threshold suspend insulin pump systems, the first devices to be classified as artificial pancreas technology, effective May 1, 2015. The Endocrine Society had urged United Healthcare...
Endocrine Society — IPEN Guide on EDCs Now Available in Spanish
Last December the Endocrine Society and IPEN, a leading global network of 700 non-governmental organizations (NGOs) working to establish and implement safe chemicals policies and practices, collaborated on the publication of Introduction to Endocrine-Disrupting Chemicals (EDCs): A Guide for Public Interest Organizations and Policy Makers. The purpose of the Guide is to raise global awareness...
The Endocrine Society is working with the Diabetes Congressional Caucus to increase support for various diabetes-related bills. On June 8, the Society participated in a Diabetes Congressional Caucus legislative briefing to provide information to congressional staff on diabetes legislation in the 114th Congress and to increase the number of co-sponsors on diabetes legislation. The Society...
The Endocrine Society supports the U.S. National Bone Health Alliance (NBHA) response to the May 26 British Medical Journal paper, “Overdiagnosis of bone fragility in the quest to prevent hip fracture,” disputing the paper’s authors’ argument “that evidence for stratifying risk of fracture and subsequent drug therapy to prevent hip fracture is insufficient to warrant...
President Barack Obama’s nomination of acting administrator Andy Slavitt to be administrator of the Centers for Medicare and Medicaid Services leaves Senate Republicans weighing how to orchestrate the confirmation process in their favor. The Senate could use a confirmation hearing to rehash the stumbles of the 2010 healthcare overhaul, particularly the launch of the federal...
Endocrinology Advocacy
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
